Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case report

doi:10.5306/wjco.v10.i7.247

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5072)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

295

WORD

182

HTML

2965

Figures (1-4)

167

Tables (1-1)

127

Sum=3736

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

654

Download

682

Sum=1336

Jul 24, 2019 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Jul 24, 2019; 10(7): 247-255
Published online Jul 24, 2019. doi: 10.5306/wjco.v10.i7.247

Full Size Figure Download Figure

Figure 4 Biopsy of a lymph node after nivolumab treatment. Activation of a lymph node including increased Ki-67 positive interfollicular population.

Citation: Passler M, Taube ET, Sehouli J, Pietzner K. Pseudo- or real progression? An ovarian cancer patient under nivolumab: A case report. World J Clin Oncol 2019; 10(7): 247-255
URL: https://www.wjgnet.com/2218-4333/full/v10/i7/247.htm
DOI: https://dx.doi.org/10.5306/wjco.v10.i7.247